Yafen Li
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Mechanisms and clinical research progress of IL-6-mediated crosstalk between the alveolar microenvironment and the immune system in patients with severe pneumonia undergoing mechanical ventilation.
Journal: Frontiers in immunology
Published: June 22, 2026
Unveiling the hidden regulators: how post-translational modifications influence the progression and treatment of hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: October 16, 2025
MiR-424-5p acts as an oncogene in Hep3B cells by activating the PI3K/AKT signaling pathway.
Journal: Frontiers in oncology
Published: October 16, 2025
Penpulimab in an adolescent patient with pancreatic neuroendocrine carcinoma with liver metastasis: A case report and literature review.
Journal: Medicine
Published: June 09, 2025
The Dual Role of RBBP7 in Esophageal Squamous Cell Carcinoma: Cell Context-Dependent Impacts on Proliferation and Radiosensitivity.
Journal: OncoTargets and therapy
Published: April 21, 2025
Clinical efficacy of direct anterior approach versus posterior lateral approach for total hip replacement in middle-aged and elderly patients of femoral neck fracture.
Journal: Scientific reports
Published: September 05, 2024
Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1/TNNC1 axis.
Journal: Antioxidants & redox signaling
Published: March 20, 2024
B7-H3-Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors.
Journal: Cancer research
Published: January 18, 2024
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia.
Journal: European journal of medical research
Published: February 25, 2022
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.
Journal: American journal of cancer research
Published: March 09, 2021
MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.
Journal: American journal of cancer research
Published: March 13, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026